News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,745 Results
Type
Article (14901)
Company Profile (299)
Press Release (266539)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79884)
Career Advice (162)
Deals (13341)
Drug Delivery (39)
Drug Development (50704)
Employer Resources (31)
FDA (5839)
Job Trends (5169)
News (145138)
Policy (10074)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21771)
ALS (125)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6034)
Artificial intelligence (259)
Autoimmune disease (114)
Automation (9)
Bankruptcy (107)
Best Places to Work (4562)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3130)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (219)
CDC (5)
Cell therapy (565)
Cervical cancer (14)
Clinical research (43673)
Collaboration (1151)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (553)
Cystic fibrosis (112)
Data (4325)
Denatured (15)
Depression (92)
Diabetes (255)
Diagnostics (1379)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (31676)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51692)
Executive appointments (622)
FDA (7593)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (982)
Gene editing (182)
Generative AI (21)
Gene therapy (490)
GLP-1 (504)
Government (1147)
Grass and pollen (3)
Guidances (166)
Healthcare (6612)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (66)
Infectious disease (1206)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7345)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1401)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2663)
Medtech (2672)
Mergers & acquisitions (6618)
Metabolic disorders (725)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1954)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (330)
Peanut (43)
People (26662)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15476)
Phase 2 (20292)
Phase 3 (12822)
Pipeline (3263)
Policy (90)
Postmarket research (853)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (651)
Real estate (1449)
Recruiting (12)
Regulatory (9901)
Reports (19)
Research institute (972)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (55)
Last 7 days (324)
Last 30 days (1168)
Last 365 days (17850)
2026 (1705)
2025 (18098)
2024 (20544)
2023 (22415)
2022 (26824)
2021 (27809)
2020 (23358)
2019 (16228)
2018 (11744)
2017 (13746)
2016 (11842)
2015 (14360)
2014 (10408)
2013 (7493)
2012 (7543)
2011 (7616)
2010 (7438)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18258)
Australia (3111)
California (7079)
Canada (1839)
China (774)
Colorado (247)
Connecticut (252)
Delaware (235)
Europe (39171)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (161)
Iowa (8)
Japan (224)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5588)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1648)
New Mexico (13)
New York (1763)
North Carolina (827)
North Dakota (6)
Northern California (3477)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1280)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (907)
United States (23351)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
281,745 Results for "moma therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MOMA Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial for MOMA-341, a Highly Potent and Selective Werner Helicase Inhibitor
July 17, 2025
·
2 min read
Press Releases
MOMA Therapeutics to Present Multiple Posters at the American Association for Cancer Research Annual Meeting 2025
April 17, 2025
·
2 min read
Press Releases
MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management Team
April 1, 2025
·
3 min read
Press Releases
MOMA Therapeutics to Participate in Upcoming Investor Conferences
November 7, 2024
·
1 min read
Business
MOMA Therapeutics Appoints Marc Ballas, M.D., as Head of Clinical Development, and Adam Thomas as Chief People & Experience Officer
MOMA Therapeutics today announced the appointments of two seasoned industry executives to the company’s leadership team. Marc Ballas, M.D., joins as SVP, head of clinical development, and Adam Thomas joins as chief people and experience officer.
June 25, 2024
·
4 min read
Business
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
MOMA Therapeutics today announced that Jullian G. Jones, Ph.D., J.D., MBA, has been appointed as the company’s chief business officer.
March 11, 2024
·
3 min read
Business
MOMA Therapeutics Announces Five-Year Discovery Collaboration with Roche Focused on Critical Cancer Dependencies
MOMA Therapeutics is pleased to announce a strategic collaboration and licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY).
January 4, 2024
·
4 min read
Press Releases
MOMA Therapeutics Provides Corporate Update and Announces Exclusive License Agreement for Selective PARP1 Inhibitor
January 8, 2025
·
3 min read
Press Releases
Bayer and MOMA Therapeutics Enter Collaboration and License Agreement in Oncology
October 8, 2024
·
4 min read
Business
Roche Inks Potential $2B Deal with MOMA, Continues Early January Hot Streak
In the third deal in as many days, Roche is paying $66 million upfront to MOMA Therapeutics to find new drugs to go after cancer cell growth, with a potential $2 billion total in milestones and royalties.
January 4, 2024
·
3 min read
·
Tyler Patchen
1 of 28,175
Next
